Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
18 08 2023
Historique:
received: 17 11 2022
medline: 21 8 2023
pubmed: 8 3 2023
entrez: 7 3 2023
Statut: ppublish

Résumé

Patients with type 1 diabetes (T1D) have higher cardiovascular disease (CVD) risk than the general population. This observational study aims to evaluate sex-related differences in CVD prevalence and CVD risk estimates in a large cohort of T1D adults. We conducted a multicenter, cross-sectional study involving 2041 patients with T1D (mean age 46 years; 44.9% women). In patients without pre-existing CVD (primary prevention), we used the Steno type 1 risk engine to estimate the 10-year risk of developing CVD events. CVD prevalence (n = 116) was higher in men than in women aged ≥55 years (19.2 vs 12.8%, P = .036), but comparable between the 2 sexes in those aged <55 years (P = .91). In patients without pre-existing CVD (n = 1925), mean 10-year estimated CVD risk was 15.4 ± 0.4% without any significant sex difference. However, stratifying this patient group by age, the 10-year estimated CVD risk was significantly higher in men than in women until age 55 years (P < .001), but this risk equalized after this age. Carotid artery plaque burden was significantly associated with age ≥55 years and with a medium and high 10-year estimated CVD risk, without any significant sex difference. Diabetic retinopathy and sensory-motor neuropathy were also associated with higher 10-year CVD risk and female sex. Both men and women with T1D are at high CVD risk. The 10-year estimated CVD risk was higher in men aged <55 years than in women of similar age, but these sex differences disappeared at age ≥55 years, suggesting that female sex was no longer protective.

Identifiants

pubmed: 36881927
pii: 7071556
doi: 10.1210/clinem/dgad127
doi:

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e789-e798

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Alessandra Dei Cas (A)

Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Division of Nutritional and Metabolic Sciences, Azienda Ospedaliero-Universitaria di Parma, 43126 Parma, Italy.

Raffaella Aldigeri (R)

Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.

Alessandro Mantovani (A)

Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, 37124 Verona, Italy.

Maria Masulli (M)

Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy.

Luisa Palmisano (L)

Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy.

Franco Cavalot (F)

Diabetes and Metabolic Diseases Unit, San Luigi Gonzaga University Hospital, 10043 Turin, Italy.

Katia Bonomo (K)

Diabetes and Metabolic Diseases Unit, San Luigi Gonzaga University Hospital, 10043 Turin, Italy.

Marco Giorgio Baroni (MG)

Department of Clinical Medicine, Life, Health & Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Neuroendocrinology and Metabolic Diseases, IRCCS Neuromed, 86077 Pozzilli, Italy.

Efisio Cossu (E)

Unit of Diabetology, Policlinico Universitario of Cagliari, 09124 Cagliari, Italy.

Gisella Cavallo (G)

Department of Experimental Medicine, Sapienza University, 00185 Rome, Italy.

Flavia Agata Cimini (FA)

Department of Experimental Medicine, Sapienza University, 00185 Rome, Italy.

Raffaella Buzzetti (R)

Department of Experimental Medicine, Sapienza University, 00185 Rome, Italy.

Carmen Mignogna (C)

Department of Experimental Medicine, Sapienza University, 00185 Rome, Italy.

Frida Leonetti (F)

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, 00185 Rome, Italy.

Simonetta Bacci (S)

Section of Endocrinology, Department of Medicine, IRCCS, Casa Sollievo della Sofferenza Hospital, 71013 San Giovanni Rotondo (FG), Italy.

Roberto Trevisan (R)

Department of Medicine and Surgery, University of Milan Bicocca, 20126 Milan, Italy.

Mario Luca Morieri (ML)

Metabolic Diseases, Department of Medicine, University of Padua, 35128 Padua, Italy.

Riccardo Maria Pollis (RM)

Metabolic Diseases, Department of Medicine, University of Padua, 35128 Padua, Italy.

Giovanni Targher (G)

Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, 37124 Verona, Italy.

Saula Vigili de Kreutzenberg (S)

Metabolic Diseases, Department of Medicine, University of Padua, 35128 Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH